Investigating The Effect Of Topical Cream Containing Coriander Seed Extract On The healing Process and Intensity of Episiotomy Pain

Investigating The Effect Of Topical Cream Containing Coriander Seed Extract On The healing Process and Intensity of Episiotomy Pain: A double– blind Clinical Trial Study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240830062904N2

Enrollment

Registered

2025-07-26

Start date

2025-07-23

Completion date

Unknown

Last updated

2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wound healing. Disruption of perineal obstetric wound

Interventions

Intervention 1: Intervention group: Topical cream containing 10% coriander seed extract in a base of Eucerin, applied topically to the episiotomy incision area, the size of a knuckle, twice a day for

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: First and Second Birth Being aged 18-45 Gestational age 37-42 Weeks Cephalic Presentation Being an only Child Vaginal delivery with mid-lateral Incision Spontaneous and Complete xpulsion Of The Placenta

Exclusion criteria

Exclusion criteria: Having a History Of Surgery or Visible lesions in the Perineum Removal Of The pair by Hand Presence of a Hematoma In The Episiotomy area Body mass index greater than or equal to 35 Rupture of Membranes more than 18 hours Chronic diseases Allergy to a specific drug Drug and psychotropic addiction

Design outcomes

Primary

Measure	Time frame
Redness. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Edema. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Ecchymosis. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Discharges. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Approximation. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Visual analog scale. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: Visual analog scale.	—

Measure

Time frame

Redness. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Edema. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Ecchymosis. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Discharges. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Approximation. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: REEDA scale.;Visual analog scale. Timepoint: First 2 hours, day 3, day 7 and day 10. Method of measurement: Visual analog scale.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Fateme Gudarzi

Yasouj University of Medical Sciences

research@yums.ac.ir+98 74 3323 5153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026